Synopsis : This Gujarat-based specialty chemicals maker dominates key pharmaceutical intermediates with 50–90% global market share and is now expanding into battery chemicals and semiconductors. Positioned at the center of the EV and energy storage boom, it is investing Rs.220 crore at its Jhagadia facility, with 10+ products under development and multiple customers already validating its electrolyte additives business.
As global supply chains shift and new-age industries demand specialized materials, select Indian chemical manufacturers are expanding beyond their traditional businesses to capture emerging opportunities. One such company is leveraging its leadership in pharmaceutical intermediates to build a presence in battery and semiconductor chemicals, positioning itself at the intersection of electric vehicles, energy storage, and advanced manufacturing.
With a market capitalization of Rs.26,936 crore, the shares of Acutaas Chemicals Limited were trading at Rs.3,290 with a 52 week range of Rs.3444.30 to Rs.1,059. Currently stock is tading at a P/E of approximately 75x.
Moving Beyond Pharma Into Future Technologies
There’s a certain irony at the heart of Acutaas Chemicals Limited’s growth story. The company built its reputation and a global market share of 50–90% in key pharmaceutical intermediates by making molecules that help people stay healthy. Now, it’s betting that the next chapter will be written not in pill bottles, but in battery cells.
Earlier known as Ami Organics, the company is based in Surat and rebranded to Acutaas Chemicals in 2025 to reflect its growing focus on speciality and custom chemical solutions. The numbers highlight just how far it has come. From a Rs.100 crore turnover milestone in 2015, the company crossed Rs.1,000 crore in FY25 and posted revenue from operations of Rs.1,339.4 crore in FY26 a near 4x jump in five years.
Pharma intermediates are still king with an 88% revenue mix in FY26 but management is intentionally deploying capital in two high barrier high opportunity segments, battery chemicals and semiconductor chemicals. Both currently contribute minimally to revenues. But that, management argues, is precisely the point they are getting in early.
Battery Chemicals Emerging as a Key Growth Pillar
The electrolyte of a lithium-ion battery is as important as the cathode or anode. And additives in the electrolyte, such as Vinylene Carbonate (VC) and Fluoroethylene Carbonate (FEC), play an outsized role in enhancing battery performance, safety and lifespan.
Acutaas is now the first Indian manufacturer of these electrolyte additives. It commercialised VC and FEC at its Jhagadia facility in Gujarat, with Phase 1 capacity of 2,000 metric tonnes per annum each. Phase 1 was inaugurated on January 19, 2026, equipped with a fully automated DCS system and indigenously developed flow technology. Phase 2 is currently under construction.
The total planned investment at Jhagadia for battery chemicals stands at approximately Rs.220 crore, with an additional Rs.40 crore earmarked for new products within the same capex envelope. Despite no commercial revenue in FY26, the business has already made meaningful progress: five-plus customers across three countries have validated the company’s battery chemical products, and two more products are close to commercialisation from a pipeline of 10-plus. The strategy is export-oriented from day one, with minimal domestic dependence.
Strong Product Pipeline Creates Long-Term Opportunity
Unlike traditional chemical businesses, Acutaas Chemicals is building a platform, not just a product line. The R&D backbone supporting this ambition is formidable: 130-plus professionals, 30-plus PhDs, 43 reaction capabilities, and 26 process patents 10 granted, 8 published, and 8 under publication.
As battery manufacturers increasingly seek supply chain alternatives to China, India-based producers with credible technology and validated products are well-placed. Acutaas’s early-mover advantage combined with indigenously developed manufacturing processes and a government tailwind behind domestic EV manufacturing positions it to capture demand as global battery supply chains continue to reorganise.
Diversification Extends Beyond Battery Chemicals
Battery chemicals aren’t the only frontier Acutaas Chemicals is pushing into. The company is also the only Indian manufacturer of photoresist chemicals highly specialised materials used in semiconductor fabrication through its 55%-owned subsidiary Baba Fine Chemicals, which posted Rs.157 million in FY26 revenue.
In 2025, the company formed Indichem Inc., a joint venture with South Korea’s J&Materials Co. Ltd., to manufacture advanced semiconductor chemicals in Gong Ju, South Korea. The facility is currently under construction, with an investment of approximately Rs.200 crore. Together, battery and semiconductor chemicals represent roughly 1.2% of current revenues but a potentially transformative share of future earnings.
Future Perspective
Acutaas Chemicals’ financial trajectory tells a compelling story on its own. EBITDA margins expanded sharply to 35.9% in FY26 from 23% in FY25, while PAT more than doubled to Rs.356.4 crore ROCE stood at 39.3% along with borrowings of just Rs.26.5 crore.
The company is investing Rs.1,000-plus crore across pharma, battery, semiconductor, R&D, and solar capex between FY23 and FY30. The renewable energy project alone with 16 MW of installed capacity already covers a majority of electricity needs across key facilities.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
